Stress Coping Training for Nurses and Diabetes Control
NCT07933159, Not applicable, Not yet recruiting, The New Model of Care, Hail Health Cluster
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Stress Coping Training for Nurses and Diabetes Control | ClinicalTrials.gov |
| NCT number | NCT07933159 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 204 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | The New Model of Care, Hail Health Cluster | ClinicalTrials.gov |
| Conditions | Psychological Stress, Type 2 Diabetes Mellitus (DM), Occupational Stress or Workplace Stress | ClinicalTrials.gov |
| Interventions | Psychological Stress Management and Coping Mechanisms for Nurses: Enhancing Glycemic Control in Patients with Type 2 Diabetes | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Baseline Demographic and Professional Characteristics of Participating Nurses | Baseline, pre-intervention [Day 0, first face-to-face interview] | Demographic and professional characteristics collected using a researcher-designed form, including: gender, age group, marital status, educational level in nursing, years of nursing experience, job position, and nationality. | ClinicalTrials.gov |
| Secondary | Perceived stress | Pretest, immediate post-test, and follow-up three months | Nurses' stress will be measure with the 14-item Perceived Stress Scale (PSS- 14; Cohen et al., 1983). Items are rated from 0 (never) to 4 (very often) with reference to the past month. The seven positively worded items (perceived self-efficacy/control) will be reverse score, and all items will be sum to give a total score from 0 to 56, with higher scores indicating greater stress. Subscale scores were computed for helplessness (seven negatively worded items, 0-28) and perceived self-efficacy/control (seven positively worded items, raw scoring, 0-28; higher scores indicating greater perceived control). | ClinicalTrials.gov |
| Secondary | Coping strategies | Pretest, immediate post-test, and follow-up three months | Coping will be measure with the 29-item revised Ways of Coping Checklist (WCCL; Vitaliano et al., 1985), which comprises five subscales: problem-focused coping (12 items), seeking social support (3 items), self-blame (3 items), wishful thinking (6 items), and avoidance (5 items). Items are rated from 1 (not at all) to 4 (to a great extent). | ClinicalTrials.gov |
| Secondary | Diabetes self-management self-efficacy | Pretest, immediate post-test, and follow-up three months | Patients will be complete the 20-item Diabetes Management Self-Efficacy Scale (DMSES; van der Bijl et al., 1999), which covers blood glucose monitoring (3 items), dietary control (10 items), physical activity (3 items), foot care (1 item), and medication intake and follow-up (3 items). Items are rated from 0 (cannot do at all) to 10 (certainly can do); total scores range from 0 to 200, with higher scores indicating greater self-efficacy, and were classified as low (\<120), moderate (120-149), or high (≥150). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)